Rebate ban to roil drug industry

The performance of Korean pharmaceutical companies have been and will be affected by the government’s policy to abandon “rebates” ― a kind of kickback given by drug companies to pharmacies, clinics and hospitals for buying their products, according to industry sources.

“The future growth of the domestic pharmaceutical industry is unclear because of dramatic changes in the business environmen...